PIERRE FABRE: EC APPROVAL FOR BRAFTOVI IN COMBINATION WITH MEKTOVI FOR TREATMENT OF ADULT PATIENTS WITH ADVANCED NSCLC WITH BRAFV600E MUTATION

Reuters · 08/30/2024 11:29

Please log in to view news